Used in research settings as a key intermediate for developing neuropharmacological agents, particularly in the synthesis of compounds targeting opioid receptors in the central nervous system. Its structure supports the design of molecules with potential analgesic activity and reduced side effects compared to current opioids. Commonly employed in medicinal chemistry for modifying bioavailability and receptor binding affinity in experimental drug candidates. Also utilized in structure-activity relationship (SAR) studies to explore the effects of molecular modifications on biological activity.